Therapy for childhood rheumatic diseases. Have we been doing enough?
Schaller
J G
JG
Department of Pediatrics, Floating Hospital for Infants and Children, Boston, Massachusetts 02111.
D000284:Administration, Oral; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001171:Arthritis, Juvenile / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D003882:Dermatomyositis / Q000188:drug therapy; D006046:Gold / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D010396:Penicillamine / Q000627:therapeutic use; D012216:Rheumatic Diseases / Q000628:therapy*; D012595:Scleroderma, Systemic / Q000188:drug therapy; D013167:Spondylitis, Ankylosing / Q000188:drug therapy
D000894:Anti-Inflammatory Agents, Non-Steroidal; D006886:Hydroxychloroquine; D006046:Gold; D010396:Penicillamine